Source:http://linkedlifedata.com/resource/pubmed/id/21691084
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2011-6-21
|
pubmed:abstractText |
Recently, 1?,25-dihydroxycholecalciferol (vitD) has received increasing interest for its effects on many tissues and organs other than bone. A number of experimental studies have shown that vitD may have an important role in modifying risk for cardiovascular disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1421-9778
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
661-8
|
pubmed:meshHeading | |
pubmed:year |
2011
|
pubmed:articleTitle |
1?,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells.
|
pubmed:affiliation |
Department of Clinical and Experimental Medicine, University of Eastern Piedmont, Novara, Italy. molinari@med.unipmn.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|